| Dr Nicholas Linehan, PHARMD | |
|
674 Islington St, Portsmouth, NH 03801-4216 | |
| (603) 431-0234 | |
| Not Available |
| Full Name | Dr Nicholas Linehan |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 674 Islington St, Portsmouth, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346964863 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PHCY-01023 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nicholas Linehan, PHARMD 674 Islington St, Portsmouth, NH 03801-4216 Ph: (603) 431-0234 | Dr Nicholas Linehan, PHARMD 674 Islington St, Portsmouth, NH 03801-4216 Ph: (603) 431-0234 |
News Archive
Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced that the US Food and Drug Administration (FDA) has approved its first two New Drug Applications (NDAs) based on its proprietary OralXR+(TM) platform technology including the first-ever 24 hour liquid sustained release product.
Ivermectin - an inexpensive, common medication already being used in Africa to treat roundworms that cause river blindness and parasites that cause elephantitis - could also be used to kill mosquitoes carrying malaria parasites, potentially "provid[ing] another useful weapon in the armory against a disease that kills around 800,000 a year, most of them small children and pregnant women," the Guardian's "Global Health Blog" reports (Boseley, 7/6).
The rarity of spinal muscular atrophy (SMA) means that promising new treatments may be tested in only a limited spectrum of patients before approval. Investigators evaluated a newly approved drug, onasemnogene abeparvovec, in a broader spectrum of patients in order to obtain expanded data on its side effects profile.
Researchers at the University of Texas Medical Branch at Galveston and the University of California-San Diego School of Medicine have published a study that offers a new understanding of a protein critical to physiological processes involved in major diseases such as diabetes and cancer. This work could help scientists design drugs to battle these disorders.
› Verified 4 days ago
David Cabral, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1390 Lafayette Rd, Portsmouth, NH 03801 Phone: 603-430-7595 Fax: 603-430-7746 | |
Rachel Duran, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1500 Lafayette Rd, Portsmouth, NH 03801 Phone: 603-430-7595 | |
Jenna H Sanborn, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 Lafayette Rd, Portsmouth, NH 03801 Phone: 603-602-9070 Fax: 603-810-6881 | |
Keleon A D J Rockett, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1390 Lafayette Rd, Portsmouth, NH 03801 Phone: 603-430-7595 | |
Mr. John Anthony Fratamico, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23 Osprey Drive, Portsmouth, NH 03801 Phone: 603-319-4649 Fax: 401-216-3352 | |
Janet Nadeau-leavitt, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 161 Corporate Dr, Portsmouth, NH 03801 Phone: 603-436-0562 Fax: 603-427-6155 | |
Maureen Mcpadden, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 117 Bow St Unit 114, Portsmouth, NH 03801 Phone: 603-303-3141 |